 | Up a level |
Journal Article
Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J. H., Zwaan, C. M., Marshall, L. V., Casanova, M., Branle, F., Malet, I., Emeremni, A. C. and Geoerger, B. (2016). Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. Eur. J. Cancer, 69. S. S49 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Waack, K., Wulff, B., Roellecke, K., Schneider, D., Paulussen, M., Zuzak, T., Laengler, A., Niehues, T., Brauer, N., Feddersen, I., Kontny, U., Calaminus, G., Dilloo, D., Irnich, M., Prokop, A., Graf, N., Hero, B., Fischer, M., Simon, T. and Reinhardt, D. (2017). Supra-Regional Study Sites to Improve the Pediatric Oncologic Patient Care and Recruitment into Early-Phase Clinical Trials: A German Model. Pediatr. Blood Cancer, 64. S. S346 - 2. HOBOKEN: WILEY. ISSN 1545-5017